{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:15:39Z","timestamp":1791256539341,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology","award":["2012ZX09J1211003C"],"award-info":[{"award-number":["2012ZX09J1211003C"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373384"],"award-info":[{"award-number":["81373384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503043"],"award-info":[{"award-number":["81503043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301099"],"award-info":[{"award-number":["81301099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"crossref","award":["2012B050500005"],"award-info":[{"award-number":["2012B050500005"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neuropharm.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T17:49:05Z","timestamp":1483724945000},"page":"260-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP\/PS1 transgenic mice via cAMP\/PKA\/CREB signaling and anti-inflammatory effects"],"prefix":"10.1016","volume":"116","author":[{"given":"Haibiao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canmao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqiang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.01.004_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4049\/jimmunol.173.1.559","article-title":"Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP","volume":"173","author":"Aronoff","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib3","article-title":"A\u00a0new device for step-down inhibitory avoidance task\u2013effects of low and high frequency in a novel device for passive inhibitory avoidance task that avoids bioimpedance variations","volume":"10","author":"Borba","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-010-1943-3","article-title":"Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25-35 or Abeta1-40 peptide in rats","volume":"212","author":"Cheng","year":"2010","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(08)60718-7","article-title":"The molecular biology of cyclic nucleotide phosphodiesterases","volume":"63","author":"Conti","year":"1999","journal-title":"Prog. Nucleic Acid. Res. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease","volume":"24","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/cn3000907","article-title":"Phosphodiesterases as therapeutic targets for Alzheimer's disease","volume":"3","author":"Garcia-Osta","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-kappaB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroscience.2015.01.058","article-title":"Donepezil improves learning and memory deficits in APP\/PS1 mice by inhibition of microglial activation","volume":"290","author":"Guo","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-2007-1014599","article-title":"Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine","volume":"22","author":"Hebenstreit","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2007.06.045","article-title":"Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain","volume":"573","author":"Hirose","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijdevneu.2005.11.001","article-title":"Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology","volume":"24","author":"Hoozemans","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/mol.53.1.23","article-title":"Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain","volume":"53","author":"Iona","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: a comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib17","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.07.050","article-title":"Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain","volume":"525","author":"Johansson","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"764","key":"10.1016\/j.neuropharm.2017.01.004_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejphar.2015.07.043","article-title":"Reducing A\u03b2 load and tau phosphorylation: emerging perspective for treating Alzheimer's disease","volume":"764","author":"Kalra","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0160-5402(86)90027-6","article-title":"Step-down-type passive avoidance- and escape-learning method. Suitability for experimental amnesia models","volume":"16","author":"Kameyama","year":"1986","journal-title":"J.\u00a0Pharmacol. Methods"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nri2634","article-title":"Transcriptional control of the inflammatory response","volume":"9","author":"Medzhitov","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","article-title":"Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)","volume":"25","author":"O'Donnell","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circulation Res."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0891-0618(00)00097-1","article-title":"Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain","volume":"20","author":"Perez-Torres","year":"2000","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib29","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/npp.2014.154","article-title":"The PDE4 inhibitor HT-0712 improves hippocampus-dependent memory in aged mice","volume":"39","author":"Peters","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinthera.2011.12.008","article-title":"Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease","volume":"34","author":"Pinner","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2015.07.004","article-title":"Acute and long-term exposure to chlorpyrifos induces cell death of basal forebrain cholinergic neurons through AChE variants alteration","author":"Pino","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40265-014-0218-4","article-title":"Apremilast: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0079-6468(08)00202-6","article-title":"PDE4 inhibitors - a review of the current field","volume":"47","author":"Press","year":"2009","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib34","first-page":"369808","article-title":"Alzheimer's disease and the amyloid cascade hypothesis: a critical review","volume":"2012","author":"Reitz","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14728222.2013.818656","article-title":"PDE4 as a target for cognition enhancement","volume":"17","author":"Richter","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjp.0704457","article-title":"Assessing the emetic potential of PDE4 inhibitors in rats","volume":"135","author":"Robichaud","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.nlm.2005.09.002","article-title":"Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action","volume":"85","author":"Rutten","year":"2006","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.114.214155","article-title":"GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species","volume":"350","author":"Rutter","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-60761-744-0_14","article-title":"Monitoring spatial learning and memory in Alzheimer's disease mouse models using the Morris Water Maze","volume":"670","author":"Scearce-Levie","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neurobiolaging.2005.03.024","article-title":"The cAMP-specific phosphodiesterase 4B mediates Abeta-induced microglial activation","volume":"27","author":"Sebastiani","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.febslet.2004.06.056","article-title":"Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-\u03baB without affecting I\u03baB degradation","volume":"571","author":"Shin","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuropharm.2013.09.015","article-title":"Improvement of spatial memory function in APPswe\/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D","volume":"77","author":"Sierksma","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib43","doi-asserted-by":"crossref","first-page":"16877","DOI":"10.1073\/pnas.0908706106","article-title":"Reversal of long-term dendritic spine alterations in Alzheimer disease models","volume":"106","author":"Smith","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib44","doi-asserted-by":"crossref","first-page":"361590","DOI":"10.1155\/2014\/361590","article-title":"The design of a quantitative western blot experiment","volume":"2014","author":"Taylor","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib45","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.172504199","article-title":"Amyloid beta -peptide inhibition of the PKA\/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling","volume":"99","author":"Vitolo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S1461145711000836","article-title":"The phosphodiesterase-4 inhibitor rolipram reverses Abeta-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats","volume":"15","author":"Wang","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib47","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/gps.2610","article-title":"The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project","volume":"26","author":"Wimo","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0925-4439(00)00083-1","article-title":"Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease","volume":"1535","author":"Yamamoto","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib49","first-page":"759","article-title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0028-3908(01)00174-5","article-title":"Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents","volume":"42","author":"Zhang","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.004_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JAD-122236","article-title":"RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-beta42-induced memory deficits in mice","volume":"38","author":"Zhang","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2013.09.055","article-title":"Chlorbipram: a novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer","volume":"721","author":"Zhang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.004_bib53","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1021\/jm701635j","article-title":"Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors","volume":"51","author":"Zheng","year":"2008","journal-title":"J.\u00a0Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:59:32Z","timestamp":1589720372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"alternative-id":["S0028390817300047"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP\/PS1 transgenic mice via cAMP\/PKA\/CREB signaling and anti-inflammatory effects","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}